SCHEMBL19360132

SCHEMBL19360132

C[C@H]1[C@H](O)C(C)(C)CC2C3=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@@]4(C)[C@]3(C)C[C@@H](O)[C@]21CO

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 10/20 0.79
▸ AKR1B10 O60218 3/20 0.61
▸ AKR1B1 P15121 1/20 0.61
▸ ALOX5 P09917 2/20 0.60
▸ F3 P13726 3/20 0.58
▸ SIRT5 Q9NXA8 3/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ OXTR P30559 1/20 0.58
▸ AVPR1A P37288 1/20 0.58
▸ CD81 P60033 1/20 0.58
▸ USP2 O75604 2/20 0.57
▸ POLB P06746 3/20 0.53
▸ PTPN2 P17706 3/20 0.53
▸ PSMB11 A5LHX3 2/20 0.53
▸ PSMA7 O14818 2/20 0.53
▸ PLA2G1B P04054 2/20 0.53
▸ PTPRC P08575 2/20 0.53
▸ PTPRF P10586 2/20 0.53
▸ PSMB1 P20618 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15883013 0.92 PTPN1 (0.79) PTPN1AKR1B10AKR1B1ALOX5F3
Barringtogenol C SCHEMBL15132635 0.92 PTPN1 (0.81) PTPN1AKR1B10AKR1B1ALOX5F3
Barringtogenol C SCHEMBL14871943 0.92 PTPN1 (0.81) PTPN1AKR1B10AKR1B1ALOX5F3
Barringtogenol C SCHEMBL1049164 0.92 PTPN1 (0.81) PTPN1AKR1B10AKR1B1ALOX5F3
SCHEMBL13559844 0.91 PTPN1 (0.66) PTPN1AKR1B10AKR1B1ALOX5F3
SCHEMBL29934333 0.88 PTPN1 (1.00) PTPN1AKR1B10AKR1B1ALOX5F3
SCHEMBL19284333 0.88 PTPN1 (1.00) PTPN1AKR1B10AKR1B1ALOX5F3
SCHEMBL13559839 0.86 PTPN1 (0.63) PTPN1AKR1B10AKR1B1ALOX5F3
SCHEMBL18407010 0.84 PTPN1 (0.58) PTPN1ALOX5F3SIRT5CYP3A4
SCHEMBL15883003 0.84 PTPN1 (0.66) PTPN1AKR1B10AKR1B1ALOX5F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170267714-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2017-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267714-A1 NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES VCAM1, EPCAM, ICAM1 PTPN1 2251/4885AKR1B10 3168/4885AKR1B1 3598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback